C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 7/00 (2006.01) A01N 63/00 (2006.01)
Patent
CA 2541511
The present invention relates to an immunogenic composition. More particularly, the present invention is a composition directed to eliciting an immune response to at least one covalent binding site of myristate on the HIV matrix protein. The present invention contemplates three categories of embodiments: protein or protein fragments, messenger RNA, or DNA/RNA. DNA/RNA compositions may be either naked or recombinant. The present invention further contemplates use with a variety of immune stimulants.
La présente invention porte sur une composition immunogénique, et notamment, sur une composition conçue pour éliciter une réponse immune par rapport à au moins un site de liaison covalente de myristate sur la protéine matricielle du VIH. La présente invention porte également sur trois catégories de formes d'exécution: une protéine ou des fragments de celle-ci, un ARN messager ou ADN/ARN, sur des compositions contenant des ADN/ARN soit nus, soit recombinants, ainsi que l'utilisation de divers stimulants immunes.
Karp Nelson M.
Na
Nmk Research Llc
LandOfFree
Immunogenic composition and method of developing a vaccine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunogenic composition and method of developing a vaccine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunogenic composition and method of developing a vaccine... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1757415